FindTrial
Sign In

Percutaneous nephrostomy and retrograde ureteral stent placement in the treatment of urosepsis

Percutaneous nephrostomy and retrograde ureteral stent placement in the treatment of urosepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035192
Enrollment
Unknown
Registered
2020-08-02
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urosepsis

Interventions

Percutaneous nephrostomy group:Percutaneous nephrostomy
Retrograde ureteral stent group:Retrograde ureteral stent

Sponsors

Jiangning Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Urosepsis caused by stones in the upper urinary tract when the patient was admitted to the hospital. Sepsis met the Sepsis-3.0 standard.

Exclusion criteria

Exclusion criteria: Obesity, ureteral stricture, or pregnancy.

Design outcomes

Primary

MeasureTime frame
SOFA score;—

Secondary

MeasureTime frame
body temperature;routine blood test;—

Countries

China

Contacts

Public ContactJianlin Lyu

Jiangning Hospital Affiliated to Nanjing Medical University

ljlls01@163.com+86 13770631917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026